Dennis C. Sgroi

48.4k citations

173 papers · 21.0k indexed · 8 hit papers · h-index 71

Molecular Biology top 0.2%
Oncology top 0.1%
Cancer Research top 0.05%
Pulmonary and Respiratory Medicine top 0.5%
Genetics top 0.5%

Co-authors: Robert A. Weinberg Daniel A. Haber Piyush B. Gupta Andrea L. Richardson Vincent J. Carey Rizwan Naeem Fernando Arenzana‐Seisdedos Thierry Delaunay
Topics: Breast Cancer Treatment Studies (51 papers)Estrogen and related hormone effects (28 papers)Advanced Breast Cancer Therapies (23 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Science New England Journal of Medicine Cell
Partner nations: United States United Kingdom Canada

In The Last Decade

Dennis C. Sgroi

168 papers receiving 20.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

2005 3.0k citations Dennis C. Sgroi et al. profile →
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

2013 1.9k citations Min Yu, Aditya Bardia et al. Science profile →
Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon

2006 748 citations Jianmin Zhang, Gromoslaw A. Smolen et al. profile →
Gene expression profiles of human breast cancer progression

2003 673 citations Xiaojun Ma, Ranelle Salunga et al. profile →
Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling

2008 567 citations Dennis C. Sgroi, Leif W. Ellisen et al. profile →
BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function

2001 541 citations Daphne W. Bell, Doke C.R. Wahrer et al. profile →
Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials

2005 518 citations Daphne W. Bell, Sara M. Haserlat et al. profile →
Gene expression profiling of the tumor microenvironment during breast cancer progression

2009 488 citations Xiaojun Ma, Sonika Dahiya et al. profile →

Peers

Countries citing papers authored by Dennis C. Sgroi

Since Specialization

Citations

This map shows the geographic impact of Dennis C. Sgroi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis C. Sgroi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis C. Sgroi more than expected).

Fields of papers citing papers by Dennis C. Sgroi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis C. Sgroi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis C. Sgroi. The network helps show where Dennis C. Sgroi may publish in the future.

Co-authorship network of co-authors of Dennis C. Sgroi

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis C. Sgroi. A scholar is included among the top collaborators of Dennis C. Sgroi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis C. Sgroi. Dennis C. Sgroi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial 2024 ·Clinical Cancer Research ·Eleftherios P. Mamounas,Hanna Bandos,Priya Rastogi,(unknown),Kai Treuner,Peter C. Lucas,Charles E. Geyer,Louis Fehrenbacher,Stephen Chia,Adam Brufsky,Janice M. Walshe,Gamini S. Soori,Shaker R. Dakhil,Soonmyung Paik,Sandra M. Swain,Dennis C. Sgroi,Catherine A. Schnabel,Norman Wolmark	7
2	Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study 2022 ·Clinical Cancer Research ·John M.S. Bartlett,Dennis C. Sgroi,Kai Treuner,Yi Zhang,Tammy Piper,Ranelle Salunga,Ikhlaaq Ahmed,Lucy Doos,(unknown),Karen J. Taylor,Elena F. Brachtel,Sarah Pirrie,Catherine A. Schnabel,Daniel Rea	25
3	Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma 2021 ·Clinical Cancer Research ·Raquel Nunes,Tal Sella,Kai Treuner,Jennifer M. Atkinson,(unknown),Yi Zhang,Pedro Exman,David J. Dabbs,Andrea L. Richardson,Catherine A. Schnabel,Dennis C. Sgroi,Steffi Oesterreich,Ashley Cimino‐Mathews,Otto Metzger	13
4	FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR+) Breast Cancer 2019 ·Clinical Cancer Research ·Joshua Z. Drago,Luigi Formisano,Dejan Juric,Andrzej Niemierko,Alberto Servetto,Seth A. Wander,Laura M. Spring,Neelima Vidula,Jerry Younger,Jeffrey Peppercorn,(unknown),(unknown),Dennis C. Sgroi,Steven J. Isakoff,Beverly Moy,Leif W. Ellisen,A. John Iafrate,Carlos L. Arteaga,Aditya Bardia	47
5	Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer 2018 ·JAMA Oncology ·Ivana Šestak,Richard Buus,Jack Cuzick,Peter Dubsky,Ralf Kronenwett,Carsten Denkert,Sean Ferree,Dennis C. Sgroi,Catherine A. Schnabel,Frederick L. Baehner,Elizabeth Mallon,Mitch Dowsett	204
6	A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes 2017 ·Clinical Cancer Research ·Yi Zhang,Brock E. Schroeder,Piiha-Lotta Jerevall,Amy Ly,(unknown),Catherine A. Schnabel,Dennis C. Sgroi	34
7	AKT1low Quiescent Cancer Cells Promote Solid Tumor Growth 2017 ·Molecular Cancer Therapeutics ·Cleidson P. Alves,Ipsita Dey‐Guha,Sheheryar Kabraji,Albert C. Yeh,Nilesh P. Talele,Xavier Solé,(unknown),Mari Mino–Kenudson,Massimo Loda,Dennis C. Sgroi,Anne‐Lise Børresen‐Dale,Hege G. Russnes,Kenneth N. Ross,Sridhar Ramaswamy	19
8	Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation 2016 ·Cancer Research ·Wayne Miles,Antonio Lembo,Angela Volorio,Elena F. Brachtel,Bin Tian,Dennis C. Sgroi,Paolo Provero,Nicholas J. Dyson	44
9	Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Compositionbreakdown → 2013 ·Science ·Min Yu,Aditya Bardia,Ben S. Wittner,Shannon L. Stott,Malgorzata E. Smas,David T. Ting,Steven J. Isakoff,Jordan C. Ciciliano,(unknown),Ajay M. Shah,Kyle Concannon,Maria Donaldson Collier,Lecia V. Sequist,Elena F. Brachtel,Dennis C. Sgroi,José Baselga,Sridhar Ramaswamy,Mehmet Toner,Daniel A. Haber,Shyamala Maheswaran	1928
10	Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence 2013 ·Clinical Cancer Research ·Yi Zhang,Catherine A. Schnabel,Brock E. Schroeder,Piiha-Lotta Jerevall,Rachel C. Jankowitz,Tommy� Fornander,Olle Stål,Adam Brufsky,Dennis C. Sgroi,Mark G. Erlander	163
11	Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker 2013 ·JNCI Journal of the National Cancer Institute ·Dennis C. Sgroi,Erin Carney,Elizabeth Zarrella,(unknown),(unknown),Dianne M. Finkelstein,Jackie Szymonifka,Atul K. Bhan,Lois E. Shepherd,Yi Zhang,Catherine A. Schnabel,Mark G. Erlander,James N. Ingle,Peggy L. Porter,Hyman B. Muss,(unknown),Dongsheng Tu,David L. Rimm,Paul E. Goss	153
12	A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas 2011 ·Clinical Cancer Research ·Meghan L. Rudd,Jessica C. Price,Sarah Fogoros,Andrew K. Godwin,Dennis C. Sgroi,Maria J. Merino,Daphne W. Bell	170
13	Cancer Cell–Associated MT1-MMP Promotes Blood Vessel Invasion and Distant Metastasis in Triple-Negative Mammary Tumors 2011 ·Cancer Research ·Jean Yannis Perentes,Nathaniel D. Kirkpatrick,Satoshi Nagano,(unknown),(unknown),Dennis C. Sgroi,Igor Garkavtsev,Lance L. Munn,Rakesh K. Jain,Yves Boucher	91
14	PIK3R1 (p85α) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer 2011 ·Cancer Research ·Mary Ellen Urick,Meghan L. Rudd,Andrew K. Godwin,Dennis C. Sgroi,Maria J. Merino,Daphne W. Bell	162
15	The Integrin αvβ3-5 Ligand MFG-E8 Is a p63/p73 Target Gene in Triple-Negative Breast Cancers but Exhibits Suppressive Functions in ER+ and erbB2+ Breast Cancers 2010 ·Cancer Research ·Chuanwei Yang,Tetsu Hayashida,Nicole Forster,(unknown),Dejun Shen,Shyamala Maheswaran,Li Chen,Karen S. Anderson,Leif W. Ellisen,Dennis C. Sgroi,Emmett V. Schmidt	58
16	Prevalence and Functional Analysis of Sequence Variants in the ATR Checkpoint Mediator Claspin 2009 ·Molecular Cancer Research ·Jianmin Zhang,Young‐Han Song,Brian W. Brannigan,Doke C.R. Wahrer,Taryn A. Schiripo,Patricia L. Harris,Sara M. Haserlat,Lindsey E. Ulkus,Kristen Shannon,Judy E. Garber,Matthew L. Freedman,Brian E. Henderson,Lee Zou,Dennis C. Sgroi,Daniel A. Haber,Daphne W. Bell	12
17	A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer 2008 ·Clinical Cancer Research ·Xiaojun Ma,Ranelle Salunga,Sonika Dahiya,Wilson Wang,Erin Carney,Virginie Durbecq,Adrian L. Harris,Paul E. Goss,Christos Sotiriou,Mark G. Erlander,Dennis C. Sgroi	227
18	Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort 2008 ·Clinical Cancer Research ·Ben S. Wittner,Dennis C. Sgroi,Paula D. Ryan,Tako J. Bruinsma,Annuska M. Glas,(unknown),Sonika Dahiya,Karleen Habin,René Bernards,Daniel A. Haber,Laura J. van’t Veer,Sridhar Ramaswamy	115
19	Frequent Met Oncogene Amplification in a Brca1/Trp53 Mouse Model of Mammary Tumorigenesis 2006 ·Cancer Research ·Gromoslaw A. Smolen,Beth Muir,Gayatry Mohapatra,Anne Barmettler,Woo Jae Kim,Miguel N. Rivera,Sara M. Haserlat,Ross A. Okimoto,Eunice L. Kwak,Sonika Dahiya,Judy E. Garber,Daphne W. Bell,Dennis C. Sgroi,Lynda Chin,Chu‐Xia Deng,Daniel A. Haber	32
20	Identification of Cyclin D1– and Estrogen-Regulated Genes Contributing to Breast Carcinogenesis and Progression 2006 ·Cancer Research ·Chuanwei Yang,(unknown),(unknown),Lan Lan,Toshi Shioda,Dennis C. Sgroi,Emmett V. Schmidt	64

About Dennis C. Sgroi

Dennis C. Sgroi is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 173 papers that have together received 21.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (51 papers), Estrogen and related hormone effects (28 papers) and Advanced Breast Cancer Therapies (23 papers). The work is most often cited by research in Cancer Research (6.8k citations), Oncology (8.7k citations) and Molecular Biology (11.1k citations). Dennis C. Sgroi has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Robert A. Weinberg, Daniel A. Haber, Piyush B. Gupta, Andrea L. Richardson, Vincent J. Carey, Rizwan Naeem, Fernando Arenzana‐Seisdedos, Thierry Delaunay, Akira Orimo and Mark G. Erlander. Their work appears in journals such as Science, New England Journal of Medicine and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact